Context Therapeutics to Participate in Upcoming Investor Conferences in November
Provided By GlobeNewswire
Last update: Oct 23, 2024
PHILADELPHIA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the Company will participate in the following investor conferences in November:
Read more at globenewswire.com0.834
-0.01 (-1.08%)
Find more stocks in the Stock Screener
CNTX Latest News and Analysis
18 days ago - ChartmillUnusual volume stocks in Friday's sessionLet's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
19 days ago - ChartmillThese stocks that are showing activity before the opening bell on Thursday.The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
